Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.120
+0.010 (0.47%)
At close: Aug 11, 2026, 4:00 PM EDT
2.140
+0.020 (0.94%)
Pre-market: Aug 12, 2026, 9:19 AM EDT
Grace Therapeutics Employees
Grace Therapeutics had 5 employees as of March 31, 2026. The number of employees decreased by 1 or -16.67% compared to the previous year.
Employees
5
Change (1Y)
-1
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,558,600
Market Cap
44.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | -1 | -16.67% |
| Mar 31, 2025 | 6 | 2 | 50.00% |
| Mar 31, 2024 | 4 | -28 | -87.50% |
| Mar 31, 2020 | 32 | 4 | 14.29% |
| Mar 31, 2019 | 28 | 17 | 154.55% |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Metagenomi Therapeutics | 118 |
| Aligos Therapeutics | 82 |
| Seres Therapeutics | 66 |
| Veru Inc. | 20 |
| Filana Therapeutics | 20 |
| Serina Therapeutics | 16 |
| Context Therapeutics | 15 |
GRCE News
- 7 days ago - Grace Therapeutics to issue 4.762M shares at $2.10 in private placement - TheFly
- 7 days ago - Grace Therapeutics initiates dual-source manufacturing strategy for GTx-104 - TheFly
- 7 days ago - Grace Therapeutics Announces $10 Million Private Placement - GlobeNewsWire
- 15 days ago - Grace Therapeutics Proxy statement: Proxy filing - Filings
- 15 days ago - Grace Therapeutics Proxy statement: Proxy filing - Filings
- 15 days ago - Grace Therapeutics receives Type A meeting minutes from FDA - TheFly
- 15 days ago - Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration - GlobeNewsWire
- 16 days ago - Grace Therapeutics Slides: Corporate presentation - Filings